OPKO Health Future Growth
Future criteria checks 1/6
OPKO Health is forecast to grow earnings and revenue by 43.3% and 6.8% per annum respectively while EPS is expected to grow by 41.7% per annum.
Key information
43.3%
Earnings growth rate
41.7%
EPS growth rate
| Healthcare earnings growth | 27.6% |
| Revenue growth rate | 6.8% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 13 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 734 | -70 | 12 | N/A | 3 |
| 12/31/2025 | 685 | -218 | -17 | N/A | 6 |
| 12/31/2024 | 685 | -159 | -183 | N/A | 6 |
| 9/30/2024 | 711 | -134 | -200 | -177 | N/A |
| 6/30/2024 | 716 | -243 | -86 | -67 | N/A |
| 3/31/2024 | 800 | -252 | -59 | -41 | N/A |
| 12/31/2023 | 863 | -189 | -44 | -28 | N/A |
| 9/30/2023 | 867 | -208 | -41 | -22 | N/A |
| 6/30/2023 | 868 | -209 | -110 | -87 | N/A |
| 3/31/2023 | 913 | -291 | -120 | -98 | N/A |
| 12/31/2022 | 1,004 | -328 | -120 | -95 | N/A |
| 9/30/2022 | 1,220 | -317 | -94 | -69 | N/A |
| 6/30/2022 | 1,426 | -202 | -28 | -4 | N/A |
| 3/31/2022 | 1,559 | -117 | -36 | -8 | N/A |
| 12/31/2021 | 1,775 | -30 | 6 | 38 | N/A |
| 9/30/2021 | 1,868 | 76 | 46 | 78 | N/A |
| 6/30/2021 | 1,910 | 71 | 73 | 108 | N/A |
| 3/31/2021 | 1,769 | 121 | 72 | 109 | N/A |
| 12/31/2020 | 1,435 | 31 | 6 | 39 | N/A |
| 9/30/2020 | 1,165 | -114 | -72 | -41 | N/A |
| 6/30/2020 | 966 | -200 | -151 | -128 | N/A |
| 3/31/2020 | 891 | -293 | -182 | -167 | N/A |
| 12/31/2019 | 902 | -315 | -185 | -173 | N/A |
| 9/30/2019 | 899 | -279 | -173 | -161 | N/A |
| 6/30/2019 | 920 | -244 | -181 | -159 | N/A |
| 3/31/2019 | 958 | -191 | -147 | -123 | N/A |
| 12/31/2018 | 990 | -153 | -137 | -109 | N/A |
| 9/30/2018 | 929 | -295 | -112 | -72 | N/A |
| 6/30/2018 | 926 | -303 | N/A | -88 | N/A |
| 3/31/2018 | 955 | -314 | N/A | -94 | N/A |
| 12/31/2017 | 966 | -305 | N/A | -92 | N/A |
| 9/30/2017 | 1,081 | -101 | N/A | -64 | N/A |
| 6/30/2017 | 1,133 | -80 | N/A | -58 | N/A |
| 3/31/2017 | 1,197 | -48 | N/A | 7 | N/A |
| 12/31/2016 | 1,117 | -48 | N/A | 32 | N/A |
| 9/30/2016 | 1,222 | -10 | N/A | -8 | N/A |
| 6/30/2016 | 1,067 | 133 | N/A | -7 | N/A |
| 3/31/2016 | 753 | 75 | N/A | -84 | N/A |
| 12/31/2015 | 492 | -30 | N/A | 164 | N/A |
| 9/30/2015 | 241 | -85 | N/A | 149 | N/A |
| 6/30/2015 | 118 | -262 | N/A | 159 | N/A |
| 3/31/2015 | 99 | -244 | N/A | 171 | N/A |
| 12/31/2014 | 91 | -172 | N/A | -90 | N/A |
| 9/30/2014 | 86 | -135 | N/A | -92 | N/A |
| 6/30/2014 | 87 | -147 | N/A | -82 | N/A |
| 3/31/2014 | 87 | -125 | N/A | -64 | N/A |
| 12/31/2013 | 97 | -115 | N/A | -56 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: XCY is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: XCY is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: XCY is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: XCY's revenue (6.8% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: XCY's revenue (6.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if XCY's Return on Equity is forecast to be high in 3 years time